AI in Cancer Diagnostics: European Market Outlook 2030

Published Date : 18/11/2024 

The European market for artificial intelligence in cancer diagnostics is poised to reach an impressive revenue of US$ 208.9 million by 2030, driven by technological advancements and increasing investments. 

The European market for artificial intelligence (AI) in cancer diagnostics is set to witness significant growth, with projections indicating a revenue of US$ 208.9 million by 2030. This growth is fueled by several factors, including the increasing incidence of cancer cases, advancements in medical technology, and substantial investments in AI healthcare solutions.

Market Segmentation and Growth

The market is segmented into software, hardware, and services. Software has emerged as the largest segment, with a revenue share of 47.88% in 2023. This segment is expected to maintain its dominance due to the growing demand for AI-driven software solutions that enhance diagnostic accuracy and efficiency.

Challenges and Opportunities

European healthcare systems face numerous challenges, including rising costs, an increasing number of cancer cases, a growing demand for healthcare facilities, and a stagnating or shrinking healthcare workforce. These issues are exacerbated by structural inefficiencies in certain countries. However, the move towards value-based healthcare is expected to improve patient outcomes and reduce costs. AI can play a crucial role in addressing these challenges by enabling earlier cancer detection, more precise diagnoses, and the development of personalized treatment plans.

Government Initiatives and Investments

Governments across Europe are recognizing the potential of AI in healthcare and are making significant investments to support its adoption. For instance, the UK government announced an investment of USD 300 billion in AI in October 2019. This investment is expected to be utilized to enhance the quality of care in public healthcare systems, thereby driving market growth.

Key Applications of AI in Cancer Diagnostics

AI applications in cancer diagnostics are already in use or awaiting deployment. These applications include

- Early Cancer Detection AI algorithms can analyze medical images and identify early signs of cancer that may be missed by human radiologists.

- Accurate Diagnosis AI models can help in making more accurate and consistent diagnoses by analyzing vast amounts of data and identifying patterns that are not evident to the human eye.

- Personalized Treatment AI can facilitate the development of personalized treatment plans by analyzing patient data and predicting the most effective therapeutic approaches.

Reasons to Subscribe to the Databook

The Horizon Databook offers a comprehensive guide to the European AI in cancer diagnostics market, providing insights that can help companies and investors make informed decisions. Key reasons to subscribe include

- Access to Comprehensive Data The databook provides over 1 million market statistics and 20,000+ reports, covering various industries and regions.

- Informed Decision Making Subscribers gain insights into market trends, customer preferences, and competitor strategies, enabling them to make informed business decisions.

- Cost-Effective Solution Recognized as the world's most cost-effective market research database, it offers high ROI through its vast repository of data and reports.

- Customizable Reports Tailored reports and analytics allow companies to focus on specific markets, demographics, or product segments, adapting to unique business needs.

- Strategic Advantage Staying updated with the latest market intelligence helps companies stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target Buyers

The Horizon Databook is designed for a diverse clientele, including

- AI in Cancer Diagnostics Companies These companies can use the databook to gain a competitive edge and identify new market opportunities.

- Investment Firms Investment firms can leverage the databook to identify viable investment areas and make informed investment decisions.

- Advisory Firms Advisory firms can use the databook to provide clients with accurate and up-to-date market insights.

- Academic Institutions Academic institutions can use the databook for research and educational purposes, often at subsidized rates.

Revenue Generation

- 30% from Investment Firms Helping investment firms identify viable opportunity areas.

- 65% from Market Participants Working with competitive and market intelligence teams of manufacturers and service providers.

- 5% from Academic and Research Institutes Supporting academic and research not-for-profit institutes with pro-bono work at subsidized rates.

Horizon Databook Overview

The Horizon Databook provides a detailed overview of continent-level data and insights on the European AI in cancer diagnostics market. It includes forecasts from 2018 to 2030, covering revenue numbers, major trends, and company profiles. This databook is an essential resource for anyone seeking to navigate the rapidly evolving landscape of AI in cancer diagnostics in Europe. 

Frequently Asked Questions (FAQS):

Q: What is the projected revenue for the European AI in cancer diagnostics market by 2030?

A: The European AI in cancer diagnostics market is expected to reach a revenue of US$ 208.9 million by 2030.

Q: What is the largest segment in the European AI in cancer diagnostics market?

A: Software is the largest segment, with a revenue share of 47.88% in 2023.

Q: How are European healthcare systems being impacted by the increasing incidence of cancer cases?

A: European healthcare systems are facing rising costs, a growing demand for healthcare facilities, and a stagnating or shrinking healthcare workforce, which are exacerbated by the increasing incidence of cancer cases.

Q: What role is the UK government playing in the AI healthcare sector?

A: The UK government announced an investment of USD 300 billion in AI in October 2019, which is expected to be utilized to enhance the quality of care in public healthcare systems.

Q: What are the key applications of AI in cancer diagnostics?

A: Key applications include early cancer detection, accurate diagnosis, and the development of personalized treatment plans. 

More Related Topics :